Cardinal Health has signed a binding Letter of Intent to extend its distribution agreement with CVS Health until June 30, 2032, maintaining its current distribution services. This extension underscores the strong partnership between the two companies. Cardinal Health also reaffirmed its fiscal year 2027 non-GAAP EPS growth guidance of 13% to 15%, and a long-term EPS growth rate of 12% to 14%. Further updates are expected during the company's Q1 earnings call on November 5, 2026.
Cardinal Health shares trade at USD 222.25 on Pluang as of October 1, 2026, with a slight 0.11% decline in the last day, reflecting steady investor interest despite the minor dip. The stock's market cap stands at $51.52 billion, while CVS Health shares hold steady at USD 85.69 with no change on the day, balancing a 50% sell and 50% buy order activity. This stable trading environment on Pluang complements the news of Cardinal Health's extended distribution agreement with CVS Health, highlighting ongoing confidence in both companies.
Cardinal Health will announce its first-quarter financial results for fiscal year 2027 on November 5, before the New York Stock Exchange opens. The company will host a webcast at 8:30 a.m. Eastern to discuss the results, accessible via its Investor R...
Cardinal Health reported robust fiscal year 2026 results, including 14% revenue growth, a 20% increase in gross margin, and doubled free cash flow. Despite challenges like thin margins and higher current liabilities, the company remains strong with F...
